ããªã³ã©ã€ã³ãGLP-1ãã€ãšãããå®ããããã10éžïŒã¯ãªããã¯ã®å£ã³ããšè²»çšã玹ä»
PR
GLP-1ãã€ãšãããå§ããããšããæ¹ã«åããŠããªãã«ãµã¹ïœ¥ãªãŒã³ããã¯ïœ¥ãµã¯ã»ã³ãã®å¹æãéãã解説ããGLP-1ãã€ãšãããããããã®å®ããªã³ã©ã€ã³ã¯ãªããã¯10é¢ã®è¬ã®å€æ®µïœ¥çš®é¡ãšå£ã³ããã玹ä»ïŒ
GLP-1ãã€ãšããã¯æ¬åœã«ç©ãããã©ãããç©ããªããšæããŠããŸãåå ãåæããGLP-1ãã€ãšããã®å¯äœçšããªããŠã³ãçã®å±éºæ§ïœ¥ãã¡ãªããã«ã€ããŠã説æããŠããŸãã
â»åœãµã€ãã§ã玹ä»ããŠããæéã¯ç·é¡è¡šç€ºçŸ©åã«åºã¥ãå šãŠçšèŸŒäŸ¡æ Œã§ããã¯ãªããã¯æ å ±ã¯å€æŽãããŠããå Žåãããããã詳ããã¯å ¬åŒãµã€ãã確èªããŠãã ããã
ç®æ¬¡
- 1 GLP-1ãã€ãšããããããã¯ãªããã¯ã®è¬ã®å€æ®µãšçš®é¡ãæ¯èŒïŒ
- 2 GLP-1ãã€ãšããã®ããããã¯ïŒå¹æãšè¬ã®çš®é¡ã解説
- 3 GLP-1ãã€ãšãããããããïŒå®ããªã³ã©ã€ã³ã¯ãªããã¯10éžã®å£ã³ã玹ä»
- 3.1 DMMãªã³ã©ã€ã³ã¯ãªããã¯
- 3.2 ã¯ãªããã¯ãã©ã¢
- 3.3 TCBæ±äº¬äžå€®çŸå®¹å€ç§
- 3.4 eLife(ã€ãŒã©ã€ã)
- 3.5 æ¹åçŸå®¹ã¯ãªããã¯
- 3.6 MYãã¥ãŒãã£ãŒã¯ãªããã¯
- 3.7 FIREã¯ãªããã¯
- 3.8 ããžã¿ã«ã¯ãªããã¯ã°ã«ãŒã
- 3.9 ãã©ã€ããŒãã¹ãã³ã¯ãªããã¯
- 3.10 ã«ãµã³ã¯ã¯ãªããã¯
- 4 GLP-1ãã€ãšããã¯æ¬åœã«ç©ããïŒå¹æã¯ãã€ãããæéã®ç®å®ã«ã€ããŠ
- 5 GLP-1ãã€ãšããã§ç©ããªããšæããŠããŸãåå ãåæ
- 6 GLP-1ãã€ãšããã«å¯äœçšã¯ããïŒå±éºæ§ïœ¥ãã¡ãªããã説æ
- 7 GLP-1ãã€ãšããã¯ä¿éºé©çšãããïŒè²»çšçžå Žããã§ãã¯
- 8 GLP-1ãã€ãšããè¬ã¯åäººèŒžå ¥ã§ããïŒé販ã§è³Œå ¥ãããªã¹ã¯ã«ã€ããŠ
- 9 GLP-1ãã€ãšããã«é¢ãããããã質å
- 10 GLP-1ãã€ãšããã¯ãããªæ¹ã«ããããïŒããŸãšãã
GLP-1ãã€ãšããããããã¯ãªããã¯ã®è¬ã®å€æ®µãšçš®é¡ãæ¯èŒïŒ
åœèšäºã§ã¯ãGLP-1ãã€ãšãããå®ãè¡ããããããã®ã¯ãªããã¯ãšããŠãå®æé éå²åŒãªã©ã§å²å®ã«ãã€ãšããè¬ãè³Œå ¥å¯èœãªãšãããå€ãããªã³ã©ã€ã³èšºçãã§ã®GLP-1ãã€ãšããã«å¯Ÿå¿ããã¯ãªããã¯ãã玹ä»ããŠãããŸãã
åé¢ã®æ å ±ãã玹ä»ããŠããåã«ãåãæ±ã£ãŠããGLP-1ãã€ãšããå æè¬ïœ¥æ³šå°ã®å€æ®µãçš®é¡ãå²åŒç¹å žã«ã€ããŠæ¯èŒè¡šãšããŠãŸãšããã®ã§ãã§ãã¯ããŠã¿ãŠãã ããã
ã¯ãªããã¯å |
DMMãªã³ã©ã€ã³ã¯ãªãã㯠|
ã¯ãªããã¯ãã©ã¢ |
TCBæ±äº¬äžå€®çŸå®¹å€ç§ |
ã€ãŒã©ã€ã |
æ¹åçŸå®¹ã¯ãªãã㯠| MYãã¥ãŒãã£ã¯ãªãã㯠| ãã¡ã€ã€ãŒã¯ãªãã㯠| ããžã¿ã«ã¯ãªããã¯ã°ã«ãŒã | ãã©ã€ããŒãã¹ãã³ã¯ãªãã㯠| ã«ãµã³ã¯ã¯ãªãã㯠|
---|---|---|---|---|---|---|---|---|---|---|
ãªãã«ãµã¹ | ã 7,920åïœâ»1/æ (3mg/7mg/14mg) |
ã 9,350åïœ/æ (3mg/7mg/14mg) |
ïŒ | ã åå2,780åïœ/10æ¥é éåžž8,650åïœ/æ (3mg/7mg/14mg) |
ã 11,000åïœ/æ (3mg/7mg/14mg) |
ã 18,000åïœ/æ (3mg/7mg/14mg) |
ã åå11,000åïœ/æ éåžž18,000åïœ/æ (3mg/7mg/14mg) |
ã 9,350åïœ/æ (3mg/7mg/14mg) |
ã 9,900åïœ/æ (3mg/7mg/14mg) |
ã åå4,455å/æ éåžž8,910å/æ |
ãªãŒã³ãã㯠| ã 24,200å/æ¬ |
ã 29,700å/æ¬ |
ïŒ | ã 24,000åïœ/æ¬ |
24,750å/1ã¶æå(1æ¬) 2.0mg |
ïŒ | ïŒ | ïŒ | ïŒ | ïŒ |
ãµã¯ã»ã³ã | ïŒ | ïŒ | ã åå49,800åïœ/æ¬ éåžž75,000åïœ/æ¬ |
ã 19,800åïœ/æ¬ |
ã åå24,800åïœ/æ¬ éåžž59,800åïœ/æ¬ |
ã 22,000å/æ¬ |
ã åå17,800åïœ/æ¬ éåžž23,000åïœ/æ¬ |
ã 20,230å/æ¬ |
ã åå16,500å/æ¬ éåžž19,800å/æ¬ |
ïŒ |
å²åŒç¹å ž | å®æäŸ¿å² | å®æé éå²åŒ | ååãè©Šã | ãè©Šããã©ã³ | ååæéå²åŒ | ïŒ | ã¢ãã¿ãŒå²åŒ | å®æé éå²åŒ | ååæéå²åŒ | ååæéå²åŒ |
å ¬åŒãµã€ã | 詳现ã¯ãã¡ã | 詳现ã¯ãã¡ã | 詳现ã¯ãã¡ã | 詳现ã¯ãã¡ã | 詳现ã¯ãã¡ã | 詳现ã¯ãã¡ã |
ãã®åŸã¯ãGLP-1ãã€ãšããã«äœ¿çšãããè¬ã®å¹æãçš®é¡ã«ã€ããŠè§£èª¬ããŸãããããããã®ã¯ãªããã¯ã®è©³çŽ°ããã¡æ©ãç¥ããããšããæ¹ã¯ãã¡ããããã§ãã¯ããŠã¿ãŠãã ããïŒ
GLP-1ãã€ãšããã®ããããã¯ïŒå¹æãšè¬ã®çš®é¡ã解説
GLP-1ãã€ãšãããšã¯ã飲ã¿è¬ãèªå·±æ³šå°ãçšããå»çãã€ãšããã®äžçš®ã§ãããç¡çãªé£äºå¶éãéåãè¡ããªããŠãäœéæžå°ãªã©ã®ãã€ãšããå¹æãæåŸ ã§ããããããã®ãã€ãšããæ³ã§ãã
ãŸãæåã«ãGLP-1ãã€ãšããã®å¹æãç©ããã¡ã«ããºã ãè¬ã®çš®é¡ãéããªã©ã詳ãã解説ããŠãããŸãã
GLP-1ãã€ãšããã®å¹æãšãªãã«ãµã¹ïœ¥ãªãŒã³ããã¯ïœ¥ãµã¯ã»ã³ãã®ç¹åŸŽ
GLP-1ãã€ãšããã«äœ¿çšãããã®ã¯ãå
æ¥ã¯ç³å°¿ç
ã®æ²»çã«ãçšããããŠãããGLP-1å容äœäœåè¬ããšããè¬ã§ãã
GLP-1å容äœäœåè¬ã«ã¯ãå°è
žã§åæ³ãããæ¶ååšãã«ã¢ã³ã®äžçš®ã§ãããGLP-1ããè£ãäœçšããããäžèšã®ãããªã¡ã«ããºã ã§ãã€ãšããå¹æãããããããŸãã
ã»GLP-1ãã€ã³ã¹ãªã³ã®åæ³ããµããŒãããã€ã³ã¹ãªã³ã®è¡ç³å€ãäžããåãã«ãã£ãŠé£åŸã®è¡ç³å€ã®æ¥äžæãæå¶ããã
âèèªãã€ãã«ããäœè³ªã«ãªã
ã»GLP-1ã«ãã£ãŠèãè
žã®åããç·©ããã«ãªããé£ã¹ç©ã®æ¶åãé
ããªã
âæºè
¹æãããŒããããå°ãªãé£äºéã§æºè¶³ã§ãã
ã»GLP-1ãè³ã®èŠåºäžéšã«ããæºè
¹äžæ¢ãåºæ¿ããæºè
¹æãåµåºãã
âèªç¶ãšé£æ¬²ãæãããã
ãã®ããã«ãGLP-1ãã€ãšããã¯3ã€ã®åãã«ããé£äºã®éãç¡çãªãæžããã€ã€ãäœè³ªã倪ãã«ããç¶æ ã«æŽããŠãããã®ãç¹åŸŽã§ãã
çŸåšãGLP-1å容äœäœåè¬ãšããŠäž»ã«åŠæ¹ãããŠããã®ã¯ããªãã«ãµã¹ãããªãŒã³ããã¯ãããµã¯ã»ã³ããã®3çš®é¡ã§ããããããã®è¬ã®ç¹åŸŽã以äžã«ãŸãšããŸããã
ãªãã«ãµã¹ | ãªãŒã³ãã㯠| ãµã¯ã»ã³ã | |
---|---|---|---|
æäžæ¹æ³ | å æè¬ | æ³šå° | æ³šå° |
æå¹æå | ã»ãã°ã«ãã | ã»ãã°ã«ãã | ãªã©ã°ã«ãã |
æäžããé »åºŠ | 1æ¥1å (æåã®é£äºå) |
é±1å | 1æ¥1å (æãŸãã¯å€æ¹) |
çšé | 7mg ã»æçšéå§ãã4é±éã¯3mg ã»å¹æäžååã®å Žåã¯14mgãŸã§å¢éå¯ |
0.5mg ã»æäžéå§ãã4é±éã¯0.25mg ã»å¹æäžååã®å Žåã¯1.0mgãŸã§å¢éå¯ |
3.0mg ã»æäžéå§æã¯0.6mg ã»3.0mgã«éãããŸã§æ¯é±0.6mgãã€å¢éãã |
äžèšã®GLP-1ãã€ãšããè¬ã®äž»ãªéããšããŠã¯ããæäžæ¹æ³ããšãæäžããé »åºŠããæããããŸãã
GLP-1ãã€ãšããã¯ããªãã«ãµã¹ãšããå
æè¬ãæçšãããã€ãšããæ³ãšããªãŒã³ããã¯ïœ¥ãµã¯ã»ã³ããšããè¬å€ãèªå·±æ³šå°ãããã€ãšããæ³ããéžæã§ããŸãã
æäžããé »åºŠã«é¢ããŠã¯ããªãã«ãµã¹ãšãµã¯ã»ã³ãã¯1æ¥1åããªãŒã³ããã¯ã¯é±1åã®ã¿ã§è¡ãããšãå¯èœã§ãã
GLP-1ãã€ãšããè¬ã®çš®é¡ã«ãã£ãŠæäžããæ¹æ³ïœ¥é »åºŠããç°ãªããã®ã®ãã©ã®è¬ãçšãããšããŠãé¡äŒŒããäœçšæ©åºã«ãããã€ãšããå¹æãæåŸ ã§ãããããèªåã®åžæã«åã£ãæ¹æ³ã§GLP-1ãã€ãšãããå§ããŠã¿ããšè¯ãã§ãããã
GLP-1ãã€ãšããã®é£²ã¿è¬ãšæ³šå°ã§å¹æã®éãã¯ããïŒ
åè¿°ããéããGLP-1ãã€ãšããè¬ã¯ã©ããåæ§ã®ã¡ã«ããºã ã§å¹æããããããŸããããã€ãšããæ³ãéžæããäžã§ãã飲ã¿è¬ãã®ãªãã«ãµã¹ãšã泚å°è¬ãã®ãªãŒã³ããã¯ïœ¥ãµã¯ã»ã³ãã§å¹æã®å€§ããã«éãããããæ°ã«ãªãæ¹ãããã®ã§ã¯ãªãã§ããããã
çµè«ããèšããšã飲ã¿è¬ãšæ³šå°ã§ã¯æ³šå°ã®æ¹ãããé«ãå¹æãæåŸ
ã§ãããšèããããŠããŸãã
飲ã¿è¬ã®å Žåãè¡æ¶²äžã«éã°ãããŸã§ã«æåã®äžéšãæ¶ååžåãããŠããŸãã®ã«å¯Ÿãã泚å°ã§ããã°çŽæ¥è¡æ¶²äžã«è¬å€ã泚å
¥ã§ããã®ã§ãå¹çããGLP-1ãåã蟌ãã§ãã€ãšããå¹æãããããããšãå¯èœã§ãã
GLP-1ãã€ãšããã®é£²ã¿è¬ãšæ³šå°ã®å¹æã®éãã説æããŸãããããããŸã§å æè¬ã®æåéïœ¥æ³šå ¥éãªã©ã«ãã£ãŠãå¹æã®çšåºŠã¯å€åãããããè¬ã®çš®é¡ã ãã§å¹æã®éããå€æããã®ã¯é£ãããšããã®ãå®éã®ãšããã§ãã
ããé«ããã€ãšããå¹æãåŸãããšããåžæãããæ¹ã¯ãGLP-1ãã€ãšãããç¶ããŠããäžã§å»åž«ãšé©å®çžè«ããªãããæåã®å«æéãå€ãå æè¬ãžã®ç§»è¡ãæ³šå ¥ããè¬å€ã®å¢éãªã©ãæ€èšããŠã¿ããšè¯ãã§ãããã
GLP-1ãã€ãšãããããããïŒå®ããªã³ã©ã€ã³ã¯ãªããã¯10éžã®å£ã³ã玹ä»
ã§ã¯ããããã¯ãGLP-1ãã€ãšããã«ããããã®ãªã³ã©ã€ã³ã¯ãªããã¯10éžã玹ä»ããŠãããŸãã
åã¯ãªããã¯ã®æéã ãã§ãªããç¹åŸŽãå£ã³ãã玹ä»ããŠããã®ã§ãã¯ãªããã¯éžã³ã®åèã«ããŠã¿ãŠãã ããïŒ
DMMãªã³ã©ã€ã³ã¯ãªããã¯
DMMãªã³ã©ã€ã³ã¯ãªãã㯠GLP-1ãã€ãšããã§åŠæ¹ãããè¬ãš ãããããã©ã³ |
|
---|---|
ãªãã«ãµã¹ | â GLP-1 æ¯æ¥å
æãã©ã³ ã»3â7mg移è¡ã»ãã å®æåæïŒ13,640åïŒæ 2ã¶æç®ä»¥éïŒ16,280åïŒæ ã»3mg éåžžïŒ9,680åïŒæ å®æïŒ10,890åïŒæ 6ã¶æå®æïŒ7,920åâ»1ïŒæ ã»7mg éåžžïŒ21,780åïŒæ å®æïŒ16,280åïŒæ 6ã¶æå®æïŒ15,840åâ»1ïŒæ ã»14mg éåžžïŒ36,080åïŒæ å®æïŒ26,070åïŒæ 6ã¶æå®æïŒ25,520åâ»1ïŒæ |
ãªãŒã³ãã㯠| â GLP-1 é±1å泚å°ãã©ã³ 1æ¬ïŒ24,200å 2æ¬ïŒ47,850å 3æ¬ïŒ71,500å |
DMMãªã³ã©ã€ã³ã¯ãªããã¯ã¯ãGLP-1ãã€ãšãããªã©ã«å蚺ãããªã³ã©ã€ã³èšºçã§å¯Ÿå¿ããŠããã¯ãªããã¯ã§ããGLP-1è¬ãšããŠã¯å æè¬ã®ããªãã«ãµã¹ããåãæ±ã£ãŠããã3mg7mg14mgã®ããããããéžæããŠåŠæ¹ããŠãããããšãå¯èœã§ãã
DMMãªã³ã©ã€ã³ã¯ãªããã¯ã§ã¯åæåŠæ¹ã ãã§ãªããããããå®æ䟿ããšããå®æè³Œå ¥ãã©ã³ãèšããããŠããŠã1ã¶æ3ã¶æ6ã¶æãããå±ãééãéžãã§å¥çŽããããšã§éåžžãããå²å®ã«GLP-1ãã€ãšãããç¶ç¶ã§ããŸãããŸãã3mgãš7mgã®ãªãã«ãµã¹ãçµã¿åãããâ移è¡ãã©ã³âãçšæãããŠããã2çš®é¡ã®è¬ãçšããããšã§åŸã ã«æäžéãå¢ãããŠããããšãå¯èœã§ãã
ãªã³ã©ã€ã³åŠæ¹ãããGLPâ1ãã€ãšããè¬ã¯æçåœæ¥ã«å±ããŠããããåžæã«åãããŠã³ã³ããçãžé éããŠãããããšãå¯èœãªã®ã§ãã¹ã ãŒãºã«è¬ãåãåã£ãŠGLP-1ãã€ãšãããå§ããããã§ãããã
- ãªã³ã©ã€ã³ã®èšºçã§ãã£ãŠãå»åž«ã芪åäžå¯§ã«æ åœããŠããã
- æéã«èéãå©ããªã³ã©ã€ã³ã®ãµãŒãã¹ã¯ããããã
- ç é¢ã«è¡ããŸã§ã®äº€éè²»ãã«ããã§ããã®ã§çµæžé¢ã§ãé åç
DMMãªã³ã©ã€ã³ã¯ãªããã¯ã®å£ã³ãè©å€ã調æ»ãããšãããGLP-1ãã€ãšãããè¡ã£ãŠããæ¹ã®å£ã³ãã¯èŠåœãããŸããã§ããã
ã§ãããä»ã®èšºçã§DMMãªã³ã©ã€ã³ã¯ãªããã¯ãå蚺ããŠããæ¹ã®å£ã³ãã«ãããšããªã³ã©ã€ã³èšºçãªãã§ã¯ã®åŸ
ã¡æéã亀éè²»ãåæžã§ããç¹ã奜è©ã§ããã
å»åž«ã«ãã説æãäžå¯§ã§åãããããã£ããšããæèŠããã£ãã®ã§ãGLP-1ãã€ãšãããå§ããéã«ããã£ãããšãã€ãšããæ³ã«çŽåŸããäžã§ã¹ã¿ãŒãã§ããã§ãããã
蚺å¯æè¬ã®éæãªã© | 蚺å¯æïŒç¡æ è¬ã®é éæïŒ550å |
---|---|
å²åŒç¹å ž | å®æäŸ¿å² |
蚺çæé | å¹³æ¥ïŒ8:00ïœ22:00 åæ¥ç¥ïŒ8:00ïœ21:00 |
æ¯æãæ¹æ³ | ã¯ã¬ãžããã«ãŒããPayPayãDMMãã€ã³ã |
ã¯ãªããã¯æ° | ãªã³ã©ã€ã³ã§å¯Ÿå¿ |
å ¬åŒãµã€ã | https://clinic.dmm.com/ |
ã¯ãªããã¯ãã©ã¢
ã¯ãªããã¯ãã©ã¢ GLP-1ãã€ãšããã§åŠæ¹ãããè¬ãš ãããããã©ã³ |
|
---|---|
ãªãã«ãµã¹ | â GLP-1æ¯æ¥å
æãã©ã³ ã»3mg å®æé éïŒ 9,350åïŒæ éåžžïŒ11,000åïŒæ ã»7mg å®æé éïŒ 18,700åïŒæ éåžžïŒ22,000åïŒæ ã»14mg å®æé éïŒ 30,855åïŒæ éåžžïŒ36,300åïŒæ |
â GLP-1å¹æéèŠãã©ã³(ãªãã«ãµã¹+ã«ã»ãã£(SGLT2é»å®³è¬)) ã»3mg å®æé éïŒ 24,310åïŒæ éåžžïŒ28,600åïŒæ ã»7mg å®æé éïŒ 33,660åïŒæ éåžžïŒ39,600åïŒæ ã»14mg å®æé éïŒ 45,815åïŒæ éåžžïŒ53,900åïŒæ |
|
ãªãŒã³ãã㯠| â GLP-1é±1åæäžãã©ã³(2mg) 1æ¬ïŒ29,700å 2æ¬ïŒ59,400å |
ã¯ãªããã¯ãã©ã¢ã¯æ±äº¬éœå ãäžå¿ã«11é¢ããã¯ãªããã¯ã§ã察é¢èšºçã ãã§ãªãå蚺ãããªã³ã©ã€ã³èšºçã§GLP-1ãã€ãšãããè¡ãããšãå¯èœã§ãããªã³ã©ã€ã³èšºçã¯æé·24æãŸã§èšºçãè¡ã£ãŠããäŒèšºæ¥ããªããããå¿ããæ¹ã§ãéœåãåãããŠå蚺ããããäœå¶ãæŽããããŠããŸãã
GLP-1ãã€ãšããã¯å æè¬ã®ããªãã«ãµã¹ããšæ³šå°è¬ã®ããªãŒã³ããã¯ããåãæ±ã£ãŠãããæè¬æ¹æ³ãäºç®ãªã©ã®åžæã«åãããŠGLPâ1è¬ã®çš®é¡ãéžæã§ããŸãã3ã¶æåå幎åã®ãŸãšãè²·ããã©ã³ãã1ã¶æããšã®å®æé éãã©ã³ãçšæãããŠããŠããŸãšãè²·ããã©ã³ãªãæ倧10ïŒ ãªããå®æé éãã©ã³ãªã15ïŒ ãªããšè²»çšãæããããšãå¯èœã§ãã
ã¯ãªããã¯ãã©ã¢ã§ã¯GLP-1ãã€ãšããè¬ã ãã§ãªããç³ãäœå€ã«æåºãããäœçšã«ãã£ãŠãã€ãšããå¹æãããããâSGLT2é»å®³è¬âãå»ççšæŒ¢æ¹ãªã©ãåãæ±ã£ãŠããããªãã«ãµã¹ãšSGLT2é»å®³è¬ã®ã»ãããã©ã³ãèšããããŠããã®ã§ãèå³ãããæ¹ã¯äœµçšãæ€èšããŠã¿ãŠãã ããã
- GLP-1泚å°ã«ã€ããŠã®èª¬æãäžå¯§ã§åãããããã£ã
- å çãåžæããã£ãããšèããŠããããããµããŒãããã£ããããŠãã
- 芪åäžå¯§ãªå¯Ÿå¿ã§ãã¢ããã€ã¹ãè¯ãã£ã
ã¯ãªããã¯ãã©ã¢ã§GLP-1ãã€ãšãããè¡ã£ãŠããæ¹ã®å£ã³ãè©å€ã調æ»ãããšãGLP-1ãã€ãšããè¬ã®æäžæ¹æ³çã®èª¬æãåããããããå»åž«ïœ¥ã«ãŠã³ã»ã©ãŒã®äžå¯§ãªå¯Ÿå¿ãªã©ã奜è©ã§ããã
ãŸããGLP-1ãã€ãšãããå§ããŠããã®ãµããŒããã¢ããã€ã¹ãè¯ãã£ããšãã声ããã£ãã®ã§ãåããŠã®æ¹ã§ãäžæç¹ãªã©ããã£ãéã«ã¯ã¹ã ãŒãºã«å¯Ÿå¿ããŠããããã§ãããã
蚺å¯æè¬ã®éæãªã© | äºçŽïœ¥èšºå¯æïŒ0åâ»ãè¬ã®åŠæ¹ããªãå Žåã¯èšºå¯æãããããŸãã è¬ã®é éæïŒ550å (GLP-1泚å°ã¯ã¯ãŒã«äŸ¿ã®ãã1,100å) |
---|---|
å²åŒç¹å ž | å®æé éå²åŒ |
蚺çæé | 7:00ïœ24:00 (åæ¥ç¥ãªã©æ¥ã«ãã£ãŠç°ãªãå Žåãã) |
æ¯æãæ¹æ³ | ã¯ã¬ãžããã«ãŒããããããã«ãŒããAmazon PayãGMOåŸæãã代åŒã |
ã¯ãªããã¯æ° | 11é¢ |
å ¬åŒãµã€ã | https://www.clinicfor.life/telemedicine/diet/ |
TCBæ±äº¬äžå€®çŸå®¹å€ç§
TCBæ±äº¬äžå€®çŸå®¹å€ç§ GLP-1ãã€ãšããã§åŠæ¹ãããè¬ãš æéãã©ã³ |
|
---|---|
ãµã¯ã»ã³ã | â GLP-1ãã€ãšãã çŽ1ã¶æå(1æ¬)ïŒ åå49,800å éåžž75,000å çŽ2ã¶æå(2æ¬)ïŒ 120,000å çŽ4ïœ6ã¶æå(6æ¬)ïŒ 330,000å çŽ8ïœ12ã¶æå(12æ¬)ïŒ 600,000å |
TCBæ±äº¬äžå€®çŸå®¹å€ç§ã¯ãå šåœã«å€æ°ã®ã¯ãªããã¯ãæ§ãã倧æã®çŸå®¹å€ç§ïœ¥çŸå®¹ç®èç§ã§ããGLP-1ãã€ãšããã«ã¯å蚺ãããªã³ã©ã€ã³ã§å¯Ÿå¿ããŠããŠããããªé話ã§æ°å®¿äžäžç®é¢ã®å»åž«ã®èšºå¯ãåããããšã§èªå® ã§GLP-1ãã€ãšãããã¹ã¿ãŒãããããšãã§ããŸãã
GLP-1ãã€ãšããã«ã¯æ³šå°è¬ã®ããµã¯ã»ã³ãããåŠæ¹ããŠããããã€ãšãããåžæããæéã«ãã£ãŠ1æ¬ïœ¥2æ¬ïœ¥6æ¬ïœ¥12æ¬ããéžæããŠè³Œå ¥ããããšãã§ããé·æåããŸãšãè²·ãããããšã§æã ã®è²»çšãæããããŸããååãè©ŠãäŸ¡æ ŒãèšããããŠãããåæã¯éåžžãããè²»çšãæããŠGLP-1ãã€ãšãããè¡ããŸãã
TCBæ±äº¬äžå€®çŸå®¹å€ç§ã®GLP-1ãã€ãšããã¯åºæ¬çã«ãªã³ã©ã€ã³ã§å®çµã§ãããã®ã®ããã€ãšããäžã«äžå®ãªç¹ãæ°ã«ãªãç¹ããã£ãéã«ã¯æå¯ãã®TCBã§ç¡æã«ãŠã³ã»ãªã³ã°ãåããããã®ã§ãäžãäžã®éã®ãµããŒãäœå¶ããã£ãããšæŽããããŠããŸãã
- ã«ãŠã³ã»ã©ãŒã®æ¹ãå çã芪身ã«ãªã£ãŠã¢ããã€ã¹ã説æãããŠãã ãã£ã
- æéããããŠäžå¯§ã«è©±ãèããŠããã
- ãã€ãšããäžã«äžå®ãªããšãããã°LINEã§ã察å¿ããŠããã
TCBæ±äº¬äžå€®çŸå®¹å€ç§ã§GLP-1ãã€ãšãããè¡ã£ãŠããæ¹ã®å£ã³ãè©å€ã調æ»ãããšãã«ãŠã³ã»ãªã³ã°æã«èŠªèº«ã«çžè«ã«ä¹ã£ãŠããããç¹ããæéããããŠè©³ãã説æããŠããããç¹ãªã©ãã«ãŠã³ã»ã©ãŒãå»åž«ã®äžå¯§ãªå¯Ÿå¿ãé«è©äŸ¡ãããŠããŸããã
ãŸããGLP-1ãã€ãšãããå§ããŠãããLINEçã§è³ªåã«çããŠããããšããå£ã³ããèŠåããããããšãããå
å®ãããµããŒãã奜è©ã®ããã§ãã
蚺å¯æè¬ã®éæãªã© | ã«ãŠã³ã»ãªã³ã°æïŒç¡æ å蚺å蚺æïŒç¡æ |
---|---|
å²åŒç¹å ž | ååãè©Šã LINEåã ã¡éå®ã¯ãŒãã³ é§è»æéå®å šç¡æ |
蚺çæé | 10:00ïœ19:00 |
æ¯æãæ¹æ³ | çŸéãããããã«ãŒããã¯ã¬ãžããã«ãŒããã¹ãã決æž(QRã³ãŒã決æž)ãã¹ããåŸæã(QRã³ãŒã決æž)ãå»çããŒã³ |
ã¯ãªããã¯æ° | 100é¢ä»¥äž (ãªã³ã©ã€ã³å¯Ÿå¿ã¯1é¢ã®ã¿) |
å ¬åŒãµã€ã | https://aoki-tsuyoshi.com/opinfo/diet/glp-1-diet |
eLife(ã€ãŒã©ã€ã)
eLife(ã€ãŒã©ã€ã)ã¯ãªãã㯠GLP-1ãã€ãšããã§åŠæ¹ãããè¬ãš æéãã©ã³ |
|
---|---|
ãªãã«ãµã¹ | ã»3mg ãè©Šããã©ã³(10æ¥é)ïŒ 2,780å éåžž8,650åïŒæ ã»7mg ãè©Šããã©ã³(10æ¥é)ïŒ 5,380å éåžž16,400åïŒæ ã»14mg 26,200åïŒæ |
ãµã¯ã»ã³ã | 1æ¬(éã¢ã«ã³ãŒã«ç¶¿ä»)ïŒ 19,800å 2æ¬(éã¢ã«ã³ãŒã«ç¶¿ä»)ïŒ 39,200å 3æ¬(éã¢ã«ã³ãŒã«ç¶¿ä»)ïŒ 58,200å ãŸãšãã»ãã7æ¬ïŒ 131,600å ãŸãšãã»ãã10æ¬ïŒ 186,000å |
ãªãŒã³ãã㯠| 24,000åïŒæ¬ |
eLife(ã€ãŒã©ã€ã)ã¯ãªã³ã©ã€ã³èšºçå°éã®ã¯ãªããã¯ã§ãGLP-1ãã€ãšããã®ä»ã«ãèæ¯æ²»çãçŸå®¹ç®èæ²»çãªã©ã«ã察å¿ããŠããŸããåæ¥ç¥æ¥ãé¢ä¿ãªãæ¯æ¥æ7æããå€10æãŸã§èšºçããŠããã®ã§ãã©ã€ãã¹ã¿ã€ã«ã«åãããŠå蚺ããããšãå¯èœã§ãã
GLP-1ãã€ãšããè¬ãè±å¯ã«åãæ±ãããŠããã®ãç¹åŸŽã§ãå æè¬ã®ããªãã«ãµã¹ããšæ³šå°è¬ã®ããµã¯ã»ã³ããããªãŒã³ããã¯ããªã©ããéžæããŠåŠæ¹ããŠããããŸãããªãã«ãµã¹ã«ã¯10æ¥éã®ãè©Šããã©ã³ã2çš®é¡çšæãããŠããã3mgãŸãã¯7mgã®ããããã®è¬å€ã§GLP-1ãã€ãšãããå²å®ã«è©ŠããŸãã
eLifeã¯å蚺å蚺æã®èšºå¯æã ãã§ãªããè¬ã®é éæãç¡æã®ãããè¬ä»£ä»¥å€ã®è¿œå æéãããããŸããããŸããåŠæ¹ãããè¬ã¯åååœæ¥ã«çºéããŠããããã®ã§ãé éãªããã¹ã ãŒãºã«GLP-1ãã€ãšãããå§ããããã§ãããã
- äžå¯§ãªèšºå¯ã§ãç¿æ¥ãè¬ãå±ããŠå€§æºè¶³
- ã«ãŠã³ã»ã©ãŒã®æ¹ãæããè¯ãã£ã
- ã¯ãªããã¯ã«è¡ãæéããªããªãã®ã§ãšãŠã楜
eLifeã®å£ã³ãã調æ»ãããšãGLP-1ãã€ãšããã«é¢ããå
·äœçãªè©å€ã¯æçš¿ãããŠããŸããã§ãããããªã³ã©ã€ã³èšºçãªããã«ãŠã³ã»ã©ãŒãå»åž«ã«ããã«ãŠã³ã»ãªã³ã°ïœ¥èšºå¯ãäžå¯§ãšããæèŠãå€ãèŠãããŸããã
ãŸããçºé察å¿ãæ©ãããã«è¬ãå±ããŠãããããšå¥œè©ã ã£ãã®ã§ãéé¢ã®æéãåæžãã€ã€ã¹ããŒãã£ãŒã«GLP-1ãã€ãšãããå§ããããã§ãããã
蚺å¯æè¬ã®éæãªã© | 蚺å¯æïŒç¡æ è¬ã®é éæïŒç¡æ |
---|---|
å²åŒç¹å ž | ãè©Šããã©ã³ |
蚺çæé | 7:00ïœ22:00 |
æ¯æãæ¹æ³ | ã¯ã¬ãžããã«ãŒã |
ã¯ãªããã¯æ° | ãªã³ã©ã€ã³ã§å¯Ÿå¿ |
å ¬åŒãµã€ã | https://elife.clinic/lp/glp1-lp2 |
æ¹åçŸå®¹ã¯ãªããã¯
æ¹åçŸå®¹ã¯ãªãã㯠GLP-1ãã€ãšããã§åŠæ¹ãããè¬ãš æéãã©ã³ |
|
---|---|
ãªãã«ãµã¹ | ã»3mg 11,000åïŒæ ã»7mg 22,000åïŒæ ã»14mg 36,300åïŒæ |
ãµã¯ã»ã³ã | 17æ¥åïŒ åå24,800å ã¹ã¿ã³ããŒããã©ã³30æ¥åïŒ 59,800å ã¹ãã·ã£ã«ãã©ã³30æ¥åïŒ 79,800å |
ãªãŒã³ãã㯠| ã»2.0mg 24,750åïŒæ(1æ¬) |
æ¹åçŸå®¹ã¯ãªããã¯ã¯ãå šåœã«200é¢ä»¥äžå±éããŠããæ¥çæ倧æã®çŸå®¹ã¯ãªããã¯ã§ãããªã³ã©ã€ã³èšºçã§ã¯ãSBCã°ã«ãŒãã®äžã§ãå»çãã€ãšããã«ç¹åãã蚺çãè¡ã£ãŠããâæ¹åçŸå®¹ç®ãç§å ç§ã¯ãªããã¯å æ¬æšé¢âãŸãã¯âæ¹åå ç§ç®ãç§ã¯ãªããã¯çºç°é¢âã®å»åž«ã®èšºå¯ãåããäžã§GLP-1ãã€ãšãããå§ããããŸãã
GLP-1ãã€ãšãããšããŠã¯ãGLP-1å æè¬ã®ããªãã«ãµã¹ããGLP-1泚å°è¬ã®ããµã¯ã»ã³ããããªãŒã³ããã¯ããåŠæ¹ããŠããããŸãããµã¯ã»ã³ããçšããå Žåã«ã¯ååã¯17æ¥éãã€ãšãããè¡ãã18æ¥ç®ä»¥éãç¶ç¶ãåžæãããã©ãããéžæã§ããã®ã§ããŸãã¯çæéããGLP-1ãã€ãšãããè©ŠããŠã¿ãããšããæ¹ã§ãã¹ã¿ãŒãããããã§ãããã
æ¹åçŸå®¹ã¯ãªããã¯ã§ã¯çŸåšã®äœèª¿ãé£ç掻çã«ã€ããŠè©³ããå蚺ããå¿ èŠã«å¿ããŠæ¡è¡ãè¡ã£ãäžã§åŠæ¹éã調æŽããŠãããã®ã§ãå¥åº·é¢ã«ãé æ ®ããŠGLP-1ãã€ãšãããè¡ããããšããæ¹ã«ãé©ããŠããã§ãããã
- è²ã çžè«ããŠãå«ãªé¡ããã«å¯ãæ·»ã£ãŠããã
- ææ¡çšåºŠã®æ¡å ã§å€ãªæŒã売ãããªãã£ã
- äžå¯§ã«å¯Ÿå¿ããã ãããããäžå®ãªããã€ãšãããç¶ç¶ã§ããŠãã
æ¹åçŸå®¹ã¯ãªããã¯ã§GLP-1ãã€ãšãããè¡ã£ãŠããæ¹ã®å£ã³ãè©å€ã調æ»ãããšãæ©ã¿ãäžå®ã«èŠªèº«ã«å¯ãæ·»ã£ãŠãããç¹ããGLP-1ãã€ãšãããè¡ã£ãŠããéã®åãåããã«ãã¹ã ãŒãºã«å¯Ÿå¿ããŠãããç¹ãªã©ã奜è©ã§ããã
ãŸããæ¹åçŸå®¹ã¯ãªããã¯ã§ã¯GLP-1ãã€ãšãã以å€ã«ãæ§ã
ãªãã€ãšããè¬ïœ¥æœè¡ã¡ãã¥ãŒãèšããŠããŸãããæŒã売ãçããªãã®ãå蚺ããããã¡ãªããã®ããã§ãã
蚺å¯æè¬ã®éæãªã© | 蚺å¯æïŒç¡æ æ¡è¡ããã代ïŒ6,000å (å蚺ããŠæ¡è¡ãè¡ãå Žåã¯5,500å) è¬ã®é éæïŒ1,000å (1äžå以äžã®å Žåã¯ç¡æ) |
---|---|
å²åŒç¹å ž | SBCãã€ã³ãäŒå¡å¶åºŠ ãåé玹ä»å¶åºŠ |
蚺çæé | 10:00ïœ19:00â»é¢ã«ããç°ãªã |
æ¯æãæ¹æ³ | ã¯ã¬ãžããã«ãŒãã代åŒã (察é¢ã®å Žåã¯çŸéãããããã«ãŒããå©çšå¯èœ) |
ã¯ãªããã¯æ° | 140é¢ä»¥äž (ãªã³ã©ã€ã³å¯Ÿå¿ã¯2é¢) |
å ¬åŒãµã€ã | https://www.s-b-c.net/slimming/injection/saxenda/ |
MYãã¥ãŒãã£ãŒã¯ãªããã¯
MYãã¥ãŒãã£ãŒã¯ãªãã㯠GLP-1ãã€ãšããã§åŠæ¹ãããè¬ãš æéãã©ã³ |
|
---|---|
ãªãã«ãµã¹ | 3mgïŒ18,000åïŒæ 7mgïŒ39,000åïŒæ 14mgïŒ57,000åïŒæ |
ãµã¯ã»ã³ã | 22,000åïŒæ¬ |
MYãã¥ãŒãã£ãŒã¯ãªããã¯ã¯GLP-1ãã€ãšããã®ã»ããçŸå®¹ç®èç§ã圢æå€ç§ãªã©ã®èšºçã«ã察å¿ããŠããŸããé座ã«ããã¯ãªããã¯ã§ããããcuron(ã¯ãã³)ããšãããªã³ã©ã€ã³èšºçãµãŒãã¹ãå©çšããããšã§å šåœã©ãããã§ãå蚺ã§ããèªå® ã§GLP-1ãã€ãšãããå§ããããšãã§ããŸãã
GLP-1è¬ãšããŠã¯ãå æè¬ã®ããªãã«ãµã¹ããšæ³šå°è¬ã®ããµã¯ã»ã³ããã®2çš®é¡ãåŠæ¹ããŠããŸãããªãã«ãµã¹ã¯3çš®é¡ã®æåéã®è¬å€ãçšæãããŠãããçç¶ïœ¥äœèª¿ãå¹æã®åžæãªã©ãèžãŸããäžã§å»åž«ããã®éœåºŠæäžéãæ€èšããŠãããã®ã§ãäžå®ç¹ãåžæãããå Žåã«ã¯é©å®çžè«ãããšè¯ãã§ãããã
MYãã¥ãŒãã£ãŒã¯ãªããã¯ã§ã¯GLP-1è¬ä»¥å€ã«ãè€æ°ã®ãã€ãšããè¬ãå»ççšæŒ¢æ¹ãåãæ±ã£ãŠãããç©èº«æœè¡ãåããããšãã§ããã®ã§ãGLP-1ãã€ãšãããšã®äœµçšã«èå³ãããæ¹ã¯ã«ãŠã³ã»ãªã³ã°æã«è©±ãèããŠã¿ãŠãã ããã
- ã«ãŠã³ã»ãªã³ã°ããšãŠãäžå¯§ã§ãããšçŽ°ãããã¡ãã®æ©ã¿ãèããŠããã
- ç¥èããªãç§ã§ãåããããã«èª¬æããŠããã
- å çãçè·åž«ã®æ¹ããšãŠã察å¿ãæ°ããã ã£ã
MYãã¥ãŒãã£ãŒã¯ãªããã¯ã®å£ã³ãè©å€ã調æ»ãããšãããGLP-1ãã€ãšãããè¡ã£ãŠããæ¹ã®å£ã³ãã¯èŠåœãããŸããã§ããã 代ããã«ä»ã®ãã€ãšããæœè¡çãåããŠããæ¹ã®å£ã³ãã調æ»ãããšãå»åž«ãã¹ã¿ããã®ãã¬ã³ããªãŒãªå¯Ÿå¿ã奜è©ã§ã説æãäžå¯§ã§æ©ã¿ã«ã芪身ã«å¯ãæ·»ã£ãŠããããšããæèŠãå€ãã£ããããGLP-1ãã€ãšããã§ãªã³ã©ã€ã³å蚺ããå Žåã«ãåæ§ã®å¯Ÿå¿ãæåŸ ã§ããã§ãããã
蚺å¯æè¬ã®éæãªã© | å蚺æïŒ3,300å (ã«ãŠã³ã»ãªã³ã°ã®ã¿ã®å Žå) å蚺æïŒ1,100å ã¯ãã³å©çšæïŒ330å æ¡è¡è²»çšïŒ5,500å |
---|---|
å²åŒç¹å ž | ïŒ |
蚺çæé | 10:00ïœ13:30ïŒ 15:00ïœ18:30 |
æ¯æãæ¹æ³ | ã¯ã¬ãžããã«ãŒã (察é¢èšºçã®å Žåã¯çŸéãå»çããŒã³ãå¯) |
ã¯ãªããã¯æ° | 1é¢ |
å ¬åŒãµã€ã | https://mybc.jp/menu/medical-diet/ |
FIREã¯ãªããã¯
FIREã¯ãªãã㯠GLP-1ãã€ãšããã§åŠæ¹ãããè¬ãš æéãã©ã³ |
|
---|---|
ãªãã«ãµã¹ | 3mgïŒ åå11,000åïŒæ éåžž18,000åïŒæ 7mgïŒ25,000åïŒæ 14mgïŒ39,800åïŒæ |
ãµã¯ã»ã³ã | åå17,800åïŒæ¬ éåžž23,000åïŒæ¬ |
ãªãã«ãµã¹+ãµã¯ã»ã³ã | â ãªã³ã©ã€ã³ãã€ãšããã³ãŒã¹ (ãªãã«ãµã¹ïœ¥ãµã¯ã»ã³ããå«ãæ§ã ãªãã€ãšããè¬ïœ¥æŒ¢æ¹çããéžæ) ã©ã€ããã©ã³ïŒ 87,750åïŒæ ãã¬ãã¢ã ãã©ã³ïŒ 135,000åïŒæ |
FIREã¯ãªããã¯ã¯å»çãã€ãšããã«ç¹åããã¯ãªããã¯ã§ãGLP-1ãã¯ãããšãããã€ãšããè¬ãã³ãŒãã³ã°ãæœè¡ãªã©ã®å»çã®åãçµã¿åãããŠäžäººã²ãšãã«åã£ããªãŒããŒã¡ã€ãã®ãã€ãšããæ³ãææ¡ããŠãããŸãã
GLP-1ãã€ãšããè¬ã¯ãå æè¬ã®ããªãã«ãµã¹ããšæ³šå°è¬ã®ããµã¯ã»ã³ãããåãæ±ã£ãŠããŸããã©ã¡ãã®è¬ã«ãååäŸ¡æ ŒãèšããããŠããããªãã«ãµã¹ã¯åæ11,000åããµã¯ã»ã³ãã¯åæ17,800åã§GLP-1ãã€ãšãããå§ããããšãå¯èœã§ãã
FIREã¯ãªããã¯ã§ã¯ããªãã«ãµã¹ïœ¥ãµã¯ã»ã³ãçãå«ãæ§ã ãªãã€ãšããè¬ã挢æ¹ã®äžãããäœèª¿ïœ¥äœéã®å€åã«åãããŠé©ããè¬ãéµéããŠãããããªã³ã©ã€ã³ãã€ãšããã³ãŒã¹ããèšããããŠããŸãããªã³ã©ã€ã³èšºçãªããèªåã«åã£ããã€ãšãããè¡ããããšããæ¹ã¯ãã³ãŒã¹ã®å©çšãæ€èšããŠã¿ãã®ãè¯ãã§ãããã
- è¬ã®åŠæ¹ã ãã§ãªãé£äºã®ç®¡çãèªåã«åã£ãã¢ããã€ã¹ãããŠãããã
- è¬ã®éã®èª¿æŽãªã©ããå»è ããã®ãã©ããŒãéåžžã«è¯ãã£ã
- 管çæ é€å£«ããããã€ã芪身ã«ãªã£ãŠçžè«ã«ä¹ã£ãŠããã
FIREã¯ãªããã¯ã§GLP-1ãã€ãšãããè¡ã£ãŠããæ¹ã®å£ã³ãè©å€ã調æ»ãããšãGLP-1è¬ã®åŠæ¹ã ãã§ãªãã管çæ é€å£«ã«ããé£äºé¢ã®ã¢ããã€ã¹ãªã©ã®ãã€ãšããå°éé¢ãªãã§ã¯ã®ãµããŒãã奜è©ã§ããã
ãŸããFIREã¯ãªããã¯ã§ã¯ã³ãŒã¹ãå¥çŽããŠãã€ãšãããè¡ã£ãŠããæ¹ãå€ãå°è±¡ã§ãGLP-1è¬ãå«ããã€ãšããè¬ã®çš®é¡ãéãé©å®èª¿æŽããŠããããšãã声ããããŸããã
蚺å¯æè¬ã®éæãªã© | ã«ãŠã³ã»ãªã³ã°ïœ¥èšºå¯æïŒ ç¡æ è¬ã®é éæïŒç¡æ éµéè¡æ¶²æ€æ»æïŒ 5,500å |
---|---|
å²åŒç¹å ž | å»çãã€ãšããã¢ãã¿ãŒå²åŒ |
蚺çæé | 10:00ïœ19:00 |
æ¯æãæ¹æ³ | ã¯ã¬ãžããã«ãŒããéè¡æ¯èŸŒã代åŒã |
ã¯ãªããã¯æ° | 4é¢ |
å ¬åŒãµã€ã | https://www.fire-method.com/ |
ããžã¿ã«ã¯ãªããã¯ã°ã«ãŒã
ããžã¿ã«ã¯ãªããã¯ã°ã«ãŒã GLP-1ãã€ãšããã§åŠæ¹ãããè¬ãš æéãã©ã³ |
|
---|---|
ãªãã«ãµã¹ | â å
æè¬ãã£ãããã©ã³ 3mgïŒ éåžž11,000åïŒæ å®æé é9,350åïŒæ 7mgïŒ éåžž22,000åïŒæ å®æé é18,700åïŒæ 14mgïŒ éåžž36,300åïŒæ å®æé é30,855åïŒæ |
â å
æè¬ã¹ã¿ã³ããŒããã©ã³ (ãªãã«ãµã¹+ã«ã»ãã£2.5mg) 3mgïŒ éåžž31,900åïŒæ å®æé é27,115åïŒæ 7mgïŒ éåžž42,900åïŒæ å®æé é36,465åïŒæ 14mgïŒ éåžž57,200åïŒæ å®æé é48,620åïŒæ |
|
ãµã¯ã»ã³ã | â èªå·±æ³šå°ãã£ããç¶ç¶ãã©ã³ (å®æé éãã©ã³) 1æ¬ïŒ 20,230å 2æ¬ïŒ 38,286å (1æ¬ããã19,143å) |
â èªå·±æ³šå°ã¹ã¿ã³ããŒããã©ã³ (ãµã¯ã»ã³ã+ã«ã»ãã£2.5mg) éåžžïŒ 44,700åïŒæ å®æé éïŒ 37,995åïŒæ |
ããžã¿ã«ã¯ãªããã¯ã°ã«ãŒãã¯ãGLP-1ãã€ãšãããã¯ãããšããæ§ã ãªèšºçã«ãªã³ã©ã€ã³å¯Ÿå¿ããŠããã¯ãªããã¯ã§ãã24æé365æ¥èšºçãè¡ã£ãŠããã®ã§ãå¿ããæ¹ã§ãééæéã掻çšããŠå蚺ã§ããç°å¢ãæŽããããŠããŸãã
GLP-1ãã€ãšããè¬ã¯ãªãã«ãµã¹å æè¬ãšãµã¯ã»ã³ã泚å°è¬ã®2çš®é¡ãåãæ±ã£ãŠãããåå€åŠæ¹ã¯ãã¡ãããã«ã»ãã£ïœ¥ãŒãã«ã«çã®ãã€ãšããå æè¬ãå»ççšæŒ¢æ¹ãšã®äœµçšãã©ã³ãªã©ãè±å¯ã«çšæãããŠããã®ã§ãèªåã«åã£ããã€ãšãããè¡ãããšãå¯èœã§ãã
ããžã¿ã«ã¯ãªããã¯ã°ã«ãŒãã§ã¯ãå蚺以éã®èšºå¯ãç¡æã§åããããã ãã§ãªããå ¬åŒã©ã€ã³ã§ã®ãã£ããçžè«ã«ã察å¿ããŠããã®ã§ãGLP-1ãã€ãšãããè¡ã£ãŠããäžã§äºçŽ°ãªçåãªã©ããã£ãéã«ãæ°è»œã«çžè«ããããã§ãããã
ããžã¿ã«ã¯ãªããã¯ã®å£ã³ãè©å€ã調æ»ãããšããã2023幎12æçŸåšã§ã¯GLP-1ãã€ãšãããä»ã®èšºçã§å蚺ããŠããæ¹ã®å£ã³ããèŠåœãããªãã£ããããå£ã³ããæçš¿ãããéã«ã¯æ å ±ãéææŽæ°ããŸãã
蚺å¯æè¬ã®éæãªã© | å蚺æïŒ1,650å å蚺æïŒç¡æ é éæïŒ550å (ã¯ãŒã«äŸ¿ã®å Žåã¯1,100å) è¡æ¶²æ€æ»ãããïŒ7,370å |
---|---|
å²åŒç¹å ž | å®æé éå²åŒ |
蚺çæé | 24æé |
æ¯æãæ¹æ³ | ã¯ã¬ãžããã«ãŒããããããã«ãŒãã代éåŒæãéè¡æ¯èŸŒãã³ã³ããåŸæã(ã¹ã³ã¢åŸæã) |
ã¯ãªããã¯æ° | 2é¢ |
å ¬åŒãµã€ã | https://digital-clinic.life/online/diet/ |
ãã©ã€ããŒãã¹ãã³ã¯ãªããã¯
ãã©ã€ããŒãã¹ãã³ã¯ãªãã㯠GLP-1ãã€ãšããã§åŠæ¹ãããè¬ãš æéãã©ã³ |
|
---|---|
ãªãã«ãµã¹ | 3mgïŒ 9,900åïŒæ 7mgïŒ 19,800åïŒæ 14mgïŒ 38,500åïŒæ |
ãµã¯ã»ã³ã | ååïŒ16,500åïŒæ¬ (5æ¬ãŸã§ååäŸ¡æ Œã§è³Œå ¥å¯) éåžžïŒ19,800åïŒæ¬ å°çšé(14æ¥å)ïŒ 550å ã¢ã«ã³ãŒã«ç¶¿(14æ¥å)ïŒ 550å |
ãã©ã€ããŒãã¹ãã³ã¯ãªããã¯ã¯å€§éªæ¢ ç°ã«ããçŸå®¹å€ç§ïœ¥çŸå®¹ç®èç§ã§ã察é¢èšºçãåºæ¬ãšããŠããŸãããGLP-1ãã€ãšããã«ã¯ãªã³ã©ã€ã³èšºçã§å蚺ãã察å¿ããŠãããèªå® ã«ãŠå®çµãããããšãå¯èœã§ãã
GLP-1ãã€ãšãããšããŠã¯å æè¬ã®ããªãã«ãµã¹ããšæ³šå°è¬ã®ããµã¯ã»ã³ããã®åŠæ¹ãè¡ã£ãŠãããåžæããæäžæ¹æ³ãªã©ã§è¬ã®çš®é¡ãéžæããããšãå¯èœã§ãããµã¯ã»ã³ãã«ã¯ååå²åŒãèšããããŠããŠãå蚺æã§ããã°æ倧5æ¬ãŸã§å²å®ãªäŸ¡æ Œã§è³Œå ¥ã§ããŸãã
ãã©ã€ããŒãã¹ãã³ã¯ãªããã¯ã®ãªã³ã©ã€ã³èšºçã§ã¯ãLINEã¢ããªã®ãããªé話æ©èœãéããŠèšºå¯ãåããããšãå¯èœã§ããå ¬åŒLINEãåã ã¡è¿œå ããâãªã³ã©ã€ã³èšºçåžæâãšã¡ãã»ãŒãžãéãã ãã§æç¶ããé²ãããããããå¥éã¢ããªãçšæãããªã©ã®æéãçããŠå蚺ã§ããŸãã
- å çã®ã«ãŠã³ã»ãªã³ã°ãç確ã§ç¥ãããããšãç¥ããŠããã£ã
- ã«ãŠã³ã»ã©ãŒã®æ¹ãå»åž«ã®æ¹ãç©è °ãæãããã£ã
- å»åž«ã®ç¥èãè±å¯ã§å®å¿ã§ãããšãŠã芪åã ãšæãã
ãã©ã€ããŒãã¹ãã³ã¯ãªããã¯ã®å£ã³ãã調æ»ãããšãGLP-1ãã€ãšããã«é¢ããå ·äœçãªå£ã³ãã¯æçš¿ãããŠããŸããã§ããããã«ãŠã³ã»ãªã³ã°æã®å»åž«ã®èª¬æãäžå¯§ã§ãæ²»çæœè¡ã®å 容ãåãããããã£ããšè©å€ã§ããã ãŸããå®éã«éé¢ããŠããæ¹ãã¹ã¿ããã®å¯Ÿå¿ãã¯ãªããã¯ã®é°å²æ°ãé«è©äŸ¡ããŠãããããGLP-1ãã€ãšããã§ãªã³ã©ã€ã³å蚺ããéã«ãåæ§ã®å¯Ÿå¿ãæåŸ ã§ããã§ãããã
蚺å¯æè¬ã®éæãªã© | ãªã³ã©ã€ã³èšºå¯æïŒç¡æ 察é¢å蚺æïŒ3,300å 察é¢å蚺æïŒç¡æ è¬ã®é éæïŒèŠç¢ºèª(代åŒãã§æ¯æã) |
---|---|
å²åŒç¹å ž | ååæéå²åŒ |
蚺çæé | 10:30ïœ19:00 |
æ¯æãæ¹æ³ | ã¯ã¬ãžããã«ãŒã(PayPal決æž)ãéè¡æ¯èŸŒã代éåŒæ |
ã¯ãªããã¯æ° | 1é¢ |
å ¬åŒãµã€ã | https://private-skin.clinic/slimming/glp1diet/ |
ã«ãµã³ã¯ã¯ãªããã¯
ã«ãµã³ã¯ã¯ãªãã㯠GLP-1ãã€ãšããã§åŠæ¹ãããè¬ãš æéãã©ã³ |
|
---|---|
ãªãã«ãµã¹ | ã»3mg ååïŒ4,455åïŒæ éåžžïŒ8,910åïŒæ |
ã«ãµã³ã¯ã¯ãªããã¯ã¯é座ãšè¡šåéã«2é¢ããã¯ãªããã¯ã§ãGLP-1ãã€ãšãã以å€ã«ãèã®æ©ã¿ã«é¢ãã蚺çãå»çè±æ¯ãªã©ã®æœè¡ãè¡ã£ãŠããŸããå蚺ãããªã³ã©ã€ã³èšºçã«ã察å¿ããŠããŠã5ã10åçšåºŠã®å»åž«ã®èšºå¯ãåããããšã§ã¹ããŒãã£ãŒã«GLP-1è¬ãåŠæ¹ããŠãããããšãå¯èœã§ãã
GLP-1ãã€ãšããè¬ã¯ããªãã«ãµã¹ããåãæ±ã£ãŠããã1ã¶æã«1床ã®ãµã€ã¯ã«ã§é éããŠããããå®æ䟿ã§è³Œå ¥ããããšãå¯èœã§ããå¹³æ¥ã¯15æãåæ¥ç¥æ¥ã¯13æãŸã§ã«æ±ºæžãå®äºããããšã§è¬ãæçåœæ¥çºéããŠããããŸãã
ã«ãµã³ã¯ã¯ãªããã¯ã¯ã«ãŠã³ã»ãªã³ã°ã蚺å¯ãç¡æã§è¡ã£ãŠãããGLP-1ãã€ãšãããå§ããŠãããæéãæ°ã«ããã«äœåºŠã§ãå蚺ãšããŠçžè«ã§ããã®ã§ããã€ãšããäžã«äžæãªç¹ãå¿é äºããã£ãå Žåã«ã解決ããããã§ãããã
- äœãåãããªãç¶æ ã ã£ããåããããã説æããŠããã
- 決æžåŸããã«è¬ãçºéãããç¿æ¥ã«å°çãã
- 芪åã«ã«ãŠã³ã»ãªã³ã°ããŠããããã®ã§å©ãã
ã«ãµã³ã¯ã¯ãªããã¯ã®å£ã³ãã調æ»ãããšãGLP-1ãã€ãšãããè¡ã£ãŠããæ¹ã®å£ã³ãã¯èŠã€ãããŸããã§ããããä»ã®èšºçãåããæ¹ã®å£ã³ãã§ã¯ãªã³ã©ã€ã³ã«ãŠã³ã»ãªã³ã°æã®èª¬æã®åãããããã芪åãªå¯Ÿå¿ãè©å€ã§ããã
ãŸããåŠæ¹ããŠããã£ãè¬ãå蚺ããç¿æ¥ã«å±ãããšããå£ã³ãããã£ãã®ã§ãGLP-1ãã€ãšãããè¡ãå Žåã«ãã¹ã ãŒãºã«å§ãããããã§ãã
蚺å¯æè¬ã®éæãªã© | ã«ãŠã³ã»ãªã³ã°æïŒç¡æ å蚺å蚺æïŒç¡æ |
---|---|
å²åŒç¹å ž | ååæéå²åŒ |
蚺çæé | 10:30ïœ19:30 (é座é¢ã®èšºçæéã®ãããªã³ã©ã€ã³ã¯èŠç¢ºèª) |
æ¯æãæ¹æ³ | ã¯ã¬ãžããã«ãŒã |
ã¯ãªããã¯æ° | 2é¢ |
å ¬åŒãµã€ã | https://www.lecinq-clinic.jp/lp/glp_06/ |
GLP-1ãã€ãšããã¯æ¬åœã«ç©ããïŒå¹æã¯ãã€ãããæéã®ç®å®ã«ã€ããŠ
GLP-1ãã€ãšããã«ããå¹æã«ã€ããŠã¯åé ã§è§£èª¬ããŸããããGLP-1ãã€ãšãããæ€èšããŠããæ¹ã®äžã«ã¯ãGLP-1ãã€ãšããã¯æ¬åœã«ç©ããïŒããšçåããæã¡ã®æ¹ãããããšæããŸãã
GLP-1ãã€ãšããã«çšããããGLP-1å容äœäœåè¬ã®ãã¡ãããªãã«ãµã¹ããšããªãŒã³ããã¯ãã¯â2åç³å°¿ç
âã®æ²»çè¬ãšããŠåœå
æ¿èªãããŠããè¬ã§ãããã¢ã¡ãªã«ããšãŒãããã§ã¯è¥æºçã®æ²»çè¬ãšããŠãèªããããŠããŸãã
ãŸããããµã¯ã»ã³ããã«é¢ããŠã¯å
æ¥ããè¥æºçã«é©å¿ãããæ²»çè¬ãšããŠæµ·å€ã§èªå¯ãããŠãããã®ã§ãã
GLP-1å容äœäœåè¬ã¯ãçŸæç¹ã§ã¯æ¥æ¬åœå ã§ç©èº«ç®çã®è¬ãšããŠæ¿èªãããããŠããªããã®ã®ãäžççã«èŠããšè¥æºçæ²»çã«çšããããŠããäºäŸãå€ãããšãããè¡ç³å€ã®ã³ã³ãããŒã«ãé£æ¬²æå¶çã®äœçšã«ãã£ãŠãã€ãšããå¹æãæåŸ ã§ãããšèããŠè¯ãã§ãããã
-
GLP-1ãã€ãšããã®å¹æã¯ãã€ããå®æã§ããïŒ
-
GLP-1ãã€ãšãããå§ããŠããå¹æãå®æã§ãããŸã§ã®æéã¯ã2é±éãã1ã¶æçšåºŠã§äœéæžå°ãªã©ã®å€åãèŠãããããã«ãªãæ¹ãå€ãããã§ãããäžè¬çãªæéã®ç®å®ã¯ããã3ã¶æãšèšãããŠããŸãã
GLP-1ãã€ãšããã¯å°ãªãé£äºéã§ãæºè¶³ã§ããç¶æ ã«é£æ¬²ãå®å®ããã€ã€ãè¡ç³å€ã®æ¥äžæãé²ãããšã§å€ªãã«ããäœè³ªã«æŽããããšã§ãã€ãšããå¹æãããããããããããŸã§å³å¹æ§ã®ãããã€ãšããæ³ã§ã¯ãããŸããã
ãã ããäžè¬çãªãã€ãšããã®ããŒã¹ãšããŠã¯â1ã¶æã«äœéã®5ïŒ ä»¥å ã®æžéâãçæ³ãšãããŠãããããå¥åº·è¢«å®³çãé²ãã€ã€ç©ããããã«ã¯GLP-1ãã€ãšããã®ãããªæç¶çèšç»çãªãã€ãšããæ³ãããããã§ãã
GLP-1ãã€ãšããã§ç©ããªããšæããŠããŸãåå ãåæ
åé ã§ã¯ãGLP-1ãã€ãšããã®å¹æãåŸããããŸã§ã®æéãªã©ã説æããŸããããäžã«ã¯ãGLP-1ãã€ãšãããããŠãç©ããªãããšæããŠããŸã£ãŠããæ¹ãããããã§ãã
ããã§ãGLP-1ãã€ãšããã§ç©ããªãçç±ãåæãã3ã€ã®åå ããŸãšããŸããã
GLP-1ãã€ãšããã§ç©ããªãçç±ã®äžã€ã«ããã€ãšããäžã®é£ã¹éããéåç¡ç äžè¶³ãªã©ã®æªãç掻ç¿æ £ãèŠå ãšããŠèããããŸãã
ãã¡ãããGLP-1ãã€ãšããã¯ç¡çãªé£äºå¶éãéåãããã«äœéæžå°ãªã©ã®å¹æãæåŸ ã§ããã®ãã¡ãªããã§ãããè¬ã®äœçšã«ãã£ãŠé£æ¬²ãæå¶ãããèªç¶ãšé£äºéïŒæåã«ããªãŒãå°ãªããªãããšã§ãã€ãšããå¹æã«ç¹ãããããGLP-1è¬ãæäžããŠãããããšãã£ãŠã©ãã ãé£ã¹ãŠãç©ãããããšããèš³ã§ã¯ãããŸããã
ãŸããéåäžè¶³ã«ããæ¶è²»ãšãã«ã®ãŒïœ¥çèéã®æžå°ããæ ¢æ§çãªç¡ç äžè¶³ã«ããåºç€ä»£è¬ã®äœäžããã«ã¢ã³ãã©ã³ã¹ã®ä¹±ããªã©ã倪ãããããªãæªç¿æ £ã¯GLP-1ãã€ãšããã®äœçšã劚ããåå ã«ãªãåŸãããããã£ãããšãã€ãšããå¹æãåŸãããšããæ¹ã¯å»çã®åã«é Œããããããšãªããç掻ç¿æ £ã®èŠçŽããåæã«è¡ãããã«ããã®ãããããã§ãã
GLP-1ãã€ãšããã§ç©ããªããšããæ¹ã®äžã«ã¯ãã1æ¥1åãã1é±éã«1åããªã©ã®å æè¬ïœ¥æ³šå°è¬ã®æäžã®é »åºŠãå®ã£ãŠããªãæ¹ãèŠåããããŸããã
å æè¬ã飲ã¿å¿ããããšãå€ãã£ãããèªå·±æ³šå°ãè¡ãã®ãé¢åã§å 延ã°ãã«ããŠããŸã£ãããšããã¡ããšçšæ³ãå®ããã«GLP-1ãã€ãšãããè¡ã£ãŠãæ¬æ¥ã®å¹æã¯æåŸ ã§ããªããããæçšïœ¥æ³šå°ãè¡ãç¿æ £ããã£ãããšèº«ã«ä»ãããšè¯ãã§ãããã
ãã ããGLP-1ãã€ãšããè¬ã¯æäžãå¿ãããããšãã£ãŠå¿ ãããè€æ°ååããŸãšããŠæçšïœ¥æ³šå°ããŠè¯ããšã¯éããã
ãªãã«ãµã¹ |
---|
åœæ¥åã¯æçšãæ§ããç¿æ¥ããæçšãåéãã |
ãªãŒã³ãã㯠|
ã»æ¬¡åæäžãŸã§ã«2æ¥é(48æé)以äžããã°çŽã¡ã«æ³šå°ãããã®åŸã¯ãããããå®ããææ¥ã«æ³šå°ãã |
ã»æ¬¡åæäžãŸã§2æ¥é(48æé)æªæºã§ããã°æ³šå°ãæ§ãããããããå®ããææ¥ãã泚å°ãåéãã |
ãµã¯ã»ã³ã |
ã»ãã€ãæäžããŠããæéãã12æéæªæºã§ããã°çŽã¡ã«æ³šå°ãã次å以éãä»ãŸã§ãšåãæéã«æ³šå°ãã |
ã»ãã€ãæäžããŠããæéãã12æé以äžçµéããŠããå Žåã¯åœæ¥åã¯æ³šå°ãæ§ããç¿æ¥åããä»ãŸã§ãšåãæéã«æ³šå°ãåéãã |
ãšãããããã®è¬ã§é£²ã¿å¿ãæã¡å¿ãã®éã®é©åãªå¯Ÿå¿ãç°ãªããããçšæ³ããã£ãããšå®ã£ãäžã§GLP-1ãã€ãšãããç¶ç¶ããããã«ããŠãã ããã
GLP-1ãã€ãšããã§ç©ããªãåå ãšããŠãå ã 倪ã£ãŠããªãç¶æ ãããã€ãšãããå§ãããããå€åãæããããç©ããªããšæããŠããŸãã±ãŒã¹ããããŸãã
GLP-1ãã€ãšããè¬ã¯ããããBMI25以äžã®âè¥æºçâã®æ¹ã«é©å¿ããæ²»çè¬ãšãããŠãããããBMI20ååŸã®æ¹ã ãšãªããªãå¹æãå®æãã«ãããç©ãåã®æ¹ã«ã¯å¥åº·è¢«å®³çã®æããããããšããããããè¬ã®åŠæ¹èªäœãè¡ã£ãŠããªãã¯ãªããã¯ããããŸãã
GLP-1ãã€ãšããã«ãã£ãŠåžæããçæ³ã®äœéäœåã¯äººã«ãã£ãŠç°ãªãããšæããŸãããå ãã倪ã£ãŠããªãæ¹ã ãšå¹æãæãã«ãããšããããšã¯æŒãããŠãããŸãããã
GLP-1ãã€ãšããã«å¯äœçšã¯ããïŒå±éºæ§ïœ¥ãã¡ãªããã説æ
GLP-1ãã€ãšãããå§ããäžã§ãç©ãããã©ããã®å¹æã ãã§ãªããGLP-1ãã€ãšããã®å±éºæ§ãæ°ã«ãªããã€ã³ãã§ã¯ãªãã§ããããã
ããã§ã¯ãGLP-1ãã€ãšããã«ããå¯äœçšããªããŠã³ããªã©ã®ãã¡ãªããããããã©ããã詳ãã説æããŠãããŸãã
GLP-1ãã€ãšããã§åãæ°ïœ¥äœè¡ç³ãªã©ã®å¯äœçšã¯èµ·ããã解説
GLP-1ãã€ãšããã«çšããå æè¬ïœ¥æ³šå°è¬ã®æäžã«ãã£ãŠèµ·ããåŸãäž»ãªå¯äœçšã«ã€ããŠã以äžã«ãŸãšããŸããã
GLP-1ãã€ãšããè¬ã«ããäž»ãªå¯äœçš | |
---|---|
5ïŒ ä»¥äž | æªå¿ãäžç¢ãé£æ¬²æžéãªã© |
1ïœ5ïŒ æªæº | 䟿ç§ãååãè ¹éšäžå¿«æãè ¹çãæ¶åäžè¯ãé çããªããŒãŒå¢å ãªã© |
0.5ïœ1ïŒ æªæº | éŒè žãèçãããã³ãæµ®åæ§ããŸããèè žçãå³èŠç°åžžãç²åŽãç¡åçãã¢ãã©ãŒãŒå¢å ãªã© |
é »åºŠäžæ | éæç(çºç¹ïœ¥è麻ç¹ç)ãå¿ææ°å¢å ãèç³çãè¡ç®¡æ§æµ®è «ã泚å°éšäœåå¿ãªã© |
GLP-1ãã€ãšããè¬ã¯æ¶ååšå®ã«äœçšãããããäžç¢ã䟿ç§ãååãªã©ã®èè žçç¶ãæ¯èŒççºçŸé »åºŠã®é«ãå¯äœçšãšããŠæããããŸããããã®ä»ã®çç¶ã¯1ïŒ æªæºãšé »åºãããã®ã§ã¯ãªããGLP-1ãã€ãšãããè¡ã£ããããšãã£ãŠå¿ ãå¯äœçšãèµ·ãããšããèš³ã§ã¯ãããŸããã
ãŸããäœè¡ç³ãæ¥æ§èµçãªã©ãé節ãªå¯äœçšãšããŠæ·»ä»ææžã«èšèŒã¯ãããã®ã®çºçŸé »åºŠã¯äžæãšãããŠããã®ã§ããããŸã§ãããã£ãçç¶ãèµ·ããã±ãŒã¹ããããšçããŠããçšåºŠã§è¯ãã§ãããã
GLP-1ãã€ãšããã¯ãªããŠã³ãããïŒãããããšã©ããªãã
GLP-1ãã€ãšããã¯éåžžã®ãã€ãšãããšæ¯ã¹ããšãªããŠã³ããã«ãããšèšãããŠããŸãããå¿ ããã€ãšããäžã®äœéäœåãç¶æã§ãããšããèš³ã§ã¯ãªãããã€ãšããããããåŸã«ãªããŠã³ãããŠããŸãå¯èœæ§ãèããããŸãã
GLP-1ãã€ãšããã¯ãGLP-1è¬ã®æå¹æåã®äœçšã«ãã£ãŠé£æ¬²ãæãããæºè ¹æãä¿ã¡ãããããã®ã¯ãã¡ãããå°éã®é£äºã§æºè¶³ã§ããç¶æ ããã€ãšããäžã«ç¿æ £ã¥ããããšã§ãè¬ãæäžããªããŠãåæ§ã®é£äºãç¶ããããããã«ãªããå¹æãåŸãããç¶æ ãèªç¶ãšããŒãããããšããçãããããŸãã
ã§ãããGLP-1ãã€ãšãããããããããšãã£ãŠæåã«ããªãŒã®å€ãé£ç掻ã«æ»ã£ãŠããŸããšãå¹æãæç¶ãããããšãªããªããŠã³ãããŠããŸããŸãã
GLP-1ãã€ãšããããããããšããªããŠã³ãããã«ç©ããç¶æ ãä¿ã¡ãããšããæ¹ã¯ããã€ãšããäžã®é£äºéãç¿æ £ã«ãªããŸã§æ ¹æ°åŒ·ãè¬ã®æäžãç¶ãããããã€ãšããããããŠãããé£äºéã®èª¿æŽãé©åºŠãªéåãå¿æããã®ãããããã§ãã
GLP-1ãã€ãšããã¯ä¿éºé©çšãããïŒè²»çšçžå Žããã§ãã¯
GLP-1ãã€ãšããã¯å»çæ©é¢ã§åŠæ¹ãããå æè¬ã泚å°è¬ãçšããŠè¡ããããå¥åº·ä¿éºãé©çšããããšèããŠããæ¹ãããããšæããŸãã
GLP-1ãã€ãšããã«äœ¿çšãããâGLP-1å容äœäœåè¬âã®äžã«ã¯ã2åç³å°¿ç ã®æ²»çè¬ãšããŠåœå æ¿èªãããŠãããã®ãããã2åç³å°¿ç ã®æ²»çãç®çãšããŠããå Žåã«ã¯ä¿éºé©çšãããŸããããã€ãšãããç®çãšããŠGLP-1è¬ãåŠæ¹ããŠãããå Žåã¯ä¿éºãé©çšãããŸããã
ãã®ãããGLP-1ãã€ãšãããè¡ãéã«ãããè¬ä»£ãªã©ã®è²»çšã¯å šé¡èªå·±è² æ ãšãªã£ãŠããŸãã®ã§ãä¿éºé©çšãããªããšããç¹ãèžãŸããŠäºç®ãç«ãŠããšè¯ãã§ãããã
GLP-1ãã€ãšããã¯ä¿éºé©çšå€ã®èªç±èšºçã«åé¡ããããããè¬ã®å€æ®µãªã©ã¯ããããã®ã¯ãªããã¯ãèªç±ã«å®ããããšãã§ããåãå 容ã®GLP-1ãã€ãšãããè¡ãå Žåã«ãåé¢ã§è²»çšãç°ãªããŸãã
GLP-1ãã€ãšããã«ã¯ã©ããããã®æéãæããã®ããåœèšäºã§ã玹ä»ããã¯ãªããã¯10é¢ãåèã«ããè²»çšçžå Žã®ç®å®ãšããŠGLP-1ãã€ãšããè¬ã®çš®é¡å¥ã«äŸ¡æ Œåž¯ããŸãšããŸããã
è¬ã®çš®é¡ | æåéæ°é | è²»çšçžå Ž |
---|---|---|
ãªãã«ãµã¹ | 3mg/æ | 8,228åïœ18,000å |
7mg/æ | 15,708åïœ39,700å | |
14mg/æ | 25,058åïœ57,000å | |
ãªãŒã³ãã㯠| 1æ¬ | 24,000åïœ29,700å |
ãµã¯ã»ã³ã | 1æ¬ | 16,500åïœ75,000å |
GLP-1ãã€ãšããããªãã«ãµã¹å æè¬ã§è¡ãå Žåã¯ãäœçšéã®3mgã ãšæã 8,000åå°ããå§ããããé«çšéã®ãã®ã ãšæã æ°äžåçšåºŠãšãæå¹æåã®å«æéã«ãã£ãŠè²»çšçžå Žãå€åããŸãã
GLP-1ãã€ãšããããªãŒã³ããã¯ïœ¥ãµã¯ã»ã³ã泚å°è¬ã§è¡ãå Žåã¯ã1æ¬ããã20,000åçšåºŠãè²»çšçžå Žãšãªã£ãŠããŸãã
ãã ãã泚å°è¬ã¯äœè³ªãåžæããå¹æã®çšåºŠãªã©ã«ãã£ãŠèªåã§æäžéã調æŽãããããæéæ¯ã«å¿
èŠãªè¬å€ã®æ¬æ°ã¯äººã«ãã£ãŠç°ãªãã®ã§ã1ã¶æãããã«æããè²»çšã«é¢ããŠã¯ã«ãŠã³ã»ãªã³ã°ïœ¥èšºå¯æã«ç¢ºèªããŠãããšè¯ãã§ãããã
ãŸããäžéšã®GLP-1ãã€ãšããè¬ã«ååå²åŒäŸ¡æ Œïœ¥ãè©ŠãäŸ¡æ ŒãèšããŠããã¯ãªããã¯ããå®æé éã®å¥çŽã§å²å®ã«GLP-1ãã€ãšãããç¶ç¶ã§ããã¯ãªããã¯ãããã®ã§ãè²»çšãæããããšããæ¹ã¯éåžžæéã ãã§ãªãåé¢ã®å²åŒç¹å žããã§ãã¯ããŠã¿ãŠãã ããã
GLP-1ãã€ãšããããªãã¹ãè²»çšãæããŠè¡ããããšããæ¹ã¯ãè²»çšçžå ŽãèžãŸããŠè¬ã®äŸ¡æ Œãå€æããã®ã¯ãã¡ãããGLP-1ãã€ãšãããå§ããéã«æããå¥éæéã«ã€ããŠãäºåã«ç¢ºèªããŠããã®ãããããã§ãã
äž»ãªå¥éæéãšããŠã¯ãã«ãŠã³ã»ãªã³ã°ïœ¥èšºå¯æããè¡æ¶²æ€æ»æããè¬ã®é éæããªã©ãæããããŸãããã¯ãªããã¯ã«ãã£ãŠã¯ç¡æã§ã«ãŠã³ã»ãªã³ã°ã蚺å¯ã«å¯Ÿå¿ããŠãããšããããè¬ã®é éæãããããªããšãããããã®ã§ãGLP-1ãã€ãšããã«å¿ èŠãªããŒã¿ã«ã®æéã確ãããäžã§æ¯èŒïœ¥æ€èšãããšè¯ãã§ãããã
GLP-1ãã€ãšããè¬ã¯åäººèŒžå ¥ã§ããïŒé販ã§è³Œå ¥ãããªã¹ã¯ã«ã€ããŠ
GLP-1ãã€ãšããã«äœ¿çšãããGLP-1å容äœäœåè¬ã¯âåŠæ¹ç®å»è¬åâã«åºåãããŠãããå»åž«ã®èšºå¯ãåããåŠæ¹ç®ãåºããŠããã£ãäžã§åŠæ¹ããããã®ãªã®ã§ãè³Œå ¥ããããã«ã¯å»çæ©é¢ãå蚺ããå¿ èŠããããŸãã
ã§ãããã€ã³ã¿ãŒãããäžã®é販ãµã€ãã§ã¯GLP-1ãã€ãšããè¬ã®ãªãã«ãµã¹ïœ¥ãªãŒã³ããã¯ïœ¥ãµã¯ã»ã³ãçãåãæ±ã£ãŠãããšãããããããåäººèŒžå ¥ä»£è¡ãµãŒãã¹ããå©çšãããšãã圢ã§GLP-1è¬ãéè²©è³Œå ¥ããããšãå¯èœã§ãã
äžéšã®ãµã€ãã§ã¯è²»çšçžå Žãããå®ãæéã§ãªãã«ãµã¹çã販売ããŠãããšãããããã®ã§ãé販ã®å©çšãæ€èšããæ¹ããããããããŸããããGLP-1ãã€ãšããè¬ã®åäººèŒžå ¥ã«ã¯ä»¥äžã®ãããªãªã¹ã¯ããããŸãã
- è¬ã®æå¹æ§ïœ¥å®å šæ§ãä¿èšŒãããŠããªã
- èåœãŸãã¯èªå€§ãªå¹èœïœ¥å¹æãæšãŒãããŠããå Žåããã
- å質çã®ç¢ºèªããããŠãããã人äœã«æ害ãªç©è³ªãå«ãŸããŠããæãããã
- äžè¡çãªå Žææ¹æ³ã§è£œé ãããæãããã
- å¯äœçšãå¥åº·è¢«å®³ãçããéã«ãè¿ éãªå¯Ÿå¿ãå°é£ãªå Žåããã
äžèšã®ããã«ãåäººèŒžå ¥ããGLP-1ãã€ãšããå æè¬ïœ¥æ³šå°è¬ã¯å質ãå®å šæ§ãä¿èšŒãããŠããããæåŸ ãããã€ãšããå¹æãåŸãããªãã£ãããå¯äœçšãçºçŸããæããé«ãŸãã ãã§ãªããäºæãã¬å¥åº·è¢«å®³ãçããŠããŸãå¯èœæ§ãèããããŸãã
åçåŽåçã§ããå»è¬åãæµ·å€ããåäººèŒžå ¥ã§è³Œå ¥ããå±éºæ§ã«ã€ããŠæ³šæåèµ·ããŠããããšãããGLP-1ãã€ãšããè¬ãåäººèŒžå ¥ããã³é販ã§è³Œå ¥ããã®ã¯ããããã§ããŸããã
GLP-1ãã€ãšããè¬ãåäººèŒžå ¥ããããšããæ¹ã¯ãé販ãšåæ§ã«GLP-1ãã€ãšããè¬ãéµéããŠããããããªã³ã©ã€ã³èšºçãã«å¯Ÿå¿ããŠããã¯ãªããã¯ãå蚺ããã®ãããããã§ãã
GLP-1ãã€ãšããããªã³ã©ã€ã³èšºçã§è¡ãå Žåã«ã¯ã¹ããŒããã©ã³çãéããŠé éã§å»åž«ã®èšºå¯ãåããããåŠæ¹ãããGLP-1è¬ã¯èªå® ã§åãåããã®ã§ãã¯ãªããã¯ã«è¶³ãéã¶å¿ èŠããªããéé¢ããããã®äº€éè²»ãæéãæããã«GLP-1ãã€ãšãããå®çµã§ããŸãã
åœèšäºã§ã玹ä»ããGLP-1ãã€ãšãããããããã®ã¯ãªããã¯ã¯å šé¢ããªã³ã©ã€ã³èšºçã«å蚺ãã察å¿ããŠããããªã³ã©ã€ã³ãªãã§ã¯ã®å®æé éå²åŒãªã©ãèšããããŠããã¯ãªããã¯ãããã®ã§ãè²»çšãæéãåæžããŠGLP-1ãã€ãšãããè¡ãããæ¹ã¯æ€èšããŠã¿ãŠãã ããã
GLP-1ãã€ãšããã«é¢ãããããã質å
GLP-1ãã€ãšããã«ã€ããŠããããŸã§ã«è§£èª¬ã§ããªãã£ããããã質åããŸãšããŸããã
GLP-1ãã€ãšããã¯40代50代ã§ãç©ããããïŒ
GLP-1ãã€ãšãããæ€èšããŠãã40代50代ã®æ¹ã®äžã«ã¯ãGLP-1ãã€ãšããã«å¹Žéœ¢å¶éããããã©ããäžå®ã«æã£ãŠããæ¹ãããããã§ããããããŸã§å ·äœçãªå¹Žéœ¢å¶éã¯èšããããŠãããã40代50代以äžã®æ¹ã§ãåé¡ãªãGLP-1ãã€ãšãããè¡ã£ãŠå¹æãæåŸ ããããšãå¯èœã§ãã
ãã ããGLP-1ãã€ãšããè¬ã®æ·»ä»ææžã«ã¯é«éœ¢è ã®æ¹ã®æäžã«æ³šæãå¿ èŠãšã®èšèŒããããççæ©èœãäœäžããŠããæ¹ã ãšå¯äœçšã®çºçŸçãé«ãŸã£ãŠããŸãå¯èœæ§ãããã®ã§ãå¥åº·ç¶æ ãªã©ãæ°ã«æããªããGLP-1ãã€ãšãããç¶ç¶ããããã«ããŸãããã
GLP-1ãã€ãšããã«åæ»æã¯ããïŒ
GLPâ1ãã€ãšããã«éããããã€ãšãããç¶ããŠããäžã§äœéã®æžå°ãé ããªã£ãŠããŸãæéã§ããâåæ»æâã¯ä»ãç©ã§ãã
åæ»æãåŒãèµ·ããäž»ãªåå ãšããŠã¯ãããã¡ãªã¹ã¿ã·ã¹(æåžžæ§)æ©èœããçèéã®æžå°ã«ãã代è¬ã®äœäžãããã«ã¢ã³ãã©ã³ã¹ã®åœ±é¿ããªã©ãæããããããšãããé£æ¬²ã®æå¶çã«ãã£ãŠå¹æãããããGLP-1ãã€ãšãããè¡ãäžã§ãåæ»æã¯èµ·ããåŸããšèããããŸãã
ããGLP-1ãã€ãšããäžã«åæ»æãè¿ããŠããŸã£ãå Žåã«ã¯ãäžèšã®ãããªç¿æ £ãåãå ¥ããŠã¿ãã®ãããããã§ãã
âæ é€ãã©ã³ã¹ã®åããé£ç掻ãå¿æãã
âé£äºéã¯æãã€ã€ãçèéã®äœäžãé²ãããã®ã¿ã³ãã¯è³ªãããã«ã¢ã³ãã©ã³ã¹ãæŽããããã®ãã¿ãã³B6äºéãªã©ã®æåãå¿ããã
âããŒããã€ãèšãã
â2é±éïœ1ã¶æã«1åçšåºŠã®é »åºŠã§æ®æ®µãããå€ãã«ããªãŒãæåããæ©äŒãèšãã飢é€ç¶æ
ã§ãªããšèªèãããããšã§èº«äœãäžå®ç¶æ
ã«ä¿ãšããšããâãã¡ãªã¹ã¿ã·ã¹æ©èœâããªã»ãããã
âé©åºŠãªéåã«åãçµãã§ã¿ã
âæé
žçŽ éåãçãã¬ãªã©ã®é©åºŠãªéåãè¡ãããšã§åºç€ä»£è¬ã®äœäžãé²ããèèªççŒãããã身äœã®ç¶æ
ã«æŽãã
ãã ããéåžžã®ãã€ãšããã®åæ»æã«ã¯ç¡çãªé£äºå¶éçãè¡ããªããã°ãªããªãã®ã«å¯ŸããGLP-1ãã€ãšããã§ã¯åæ»æãè¿ãããšããŠãå»çã®åã«ãã£ãŠèªç¶ãšé£æ¬²ãæãããããããã¹ãã¬ã¹ãæãéããããšãªããã€ãšãããç¶ç¶ããããã§ãããã
GLP-1ãã€ãšããã¯åçåŽåçã§èªå¯ãããŠããïŒ
GLP-1ãã€ãšããã«é¢ããŠãåçåŽåçã§ã¯ãçŸå®¹å»çãåããåã«ããäžåºŠããšãã声æãçºè¡šããŠãããæäžããè¬ã«ã€ããŠã®èª¬æããã¡ããšåããŠãããããå¹æã ãã§ãªãå¯äœçšçã«ã€ããŠãææ¡ããŠããããªã©ããã£ãããšGLP-1ãã€ãšããã®å 容ã«çŽåŸããäžã§è¡ããã©ãããå€æããããšãæšå¥šããŠããŸãã
åœèšäºå ã§ãåè¿°ããŸããããGLP-1ãã€ãšããã«äœ¿çšããGLP-1å容äœäœåè¬ã¯ãããŸã§2åç³å°¿ç ã®æ²»çè¬ãšããŠåœå æ¿èªãããŠãããã®ã§ããããã€ãšããç©èº«ãç®çãšããŠèªå¯ãããŠããè¬ã§ã¯ãªããããå»åž«ããååãªèª¬æãåãããªã¹ã¯ãå±éºæ§ã«ã€ããŠãç解ããäžã§GLP-1ãã€ãšããã«èšãããã«ããŠãã ããã
GLP-1ãã€ãšããã§äœããç©ããïŒ
GLP-1ãã€ãšãããè¡ãããšã§äœããç©ãããã®åèãšããŠãã¢ã¡ãªã«ã§å ±åãããŠããGLP-1è¬ãçšããèšåºå®éšã®çµæãã玹ä»ããŸãã
被éšå¯Ÿè±¡ | 3,731人 ã»2åç³å°¿ç ã眹æ£ããŠããªãBMI30以äžã®æ¹ ã»è質ç°åžžçãŸãã¯é«è¡å§çã眹æ£ããŠããBMI27以äžã®æ¹ |
---|---|
å®éšå 容 | 被éšè ã®3åã®2ã«ãªã©ã°ã«ãã3.0mgå«æã®GLP-1泚å°è¬ãæ¯æ¥æäžããäºéç²æ€è©Šéšãå®æœ |
å®éšçµæ | âGLP-1è¬ãæäžããæ¹ã«å¹³å8.4kgã®äœéæžå°ãèŠããã âGLP-1è¬ãæäžãã63.2ïŒ ã®æ¹ã«5ïŒ ä»¥äžã®äœéæžå°ã33.1ïŒ ã®æ¹ã«10ïŒ ä»¥äžã®äœéæžå°ãèŠããã |
äžèšã®å®éšçµæã«ãããšãGLP-1è¬ã®ç®äžæ³šå°ãè¡ã£ã9å²ä»¥äžã®æ¹ã«ãã€ãšããå¹æããããå¹³å8.4kgã®äœéæžå°ã®å€åãèŠããããšå ±åãããŠããŸãã
ãã ããã玹ä»ããå®éšã®è¢«éšè ã¯BMI27ïœ30以äžã®æ¹ã«å¯Ÿè±¡ãéãããŠãããæ確ã«ãGLP-1ãã€ãšãããè¡ãããšã§ãããç©ããããšæå®ããããšã¯ã§ããªããã®ã®ãäœéæžå°ã®å¹æã¯æåŸ ã§ããã§ãããã
GLP-1ãã€ãšããã¯ãããªæ¹ã«ããããïŒããŸãšãã
GLP-1ãã€ãšããã«ã€ããŠã玹ä»ããŠãããŸãšããšããŠãGLP-1ãã€ãšãããããããã®æ¹ã®ç¹åŸŽã以äžã«ãŸãšããŸããã
- ç¡çãªé£äºå¶éãããã«äœéãæžããããæ¹
- éåãããã®ãèŠæãªæ¹
- ãªãã¹ãã¹ãã¬ã¹ãæããã«ç©ãããæ¹
- å»åž«ã®æå°ã®äžã§ãã€ãšãããè¡ãããæ¹
- èªå® ã§ãã€ãšãããæžãŸãããæ¹
GLP-1ãã€ãšããã¯ãå
æè¬ã®ãªãã«ãµã¹ãèªå·±æ³šå°è¬ã®ãªãŒã³ããã¯ïœ¥ãµã¯ã»ã³ããªã©ãçšãããã€ãšããæ³ã§ãã
æå¹æåã®äœçšã«ãããé£æ¬²ãæããŠç¡çãªãé£äºéãæžãããšãšãã«ãè¡ç³å€ã®æ¥äžæãé²ãã§å€ªãã«ããäœè³ªã«å€åãããããšã§ãç¡çãªé£äºå¶éãéåãããªããŠãäœéæžå°ãªã©ã®ãã€ãšããå¹æãæåŸ
ããããšãã§ããŸãã
ãŸããGLP-1ãã€ãšããã¯ãªã³ã©ã€ã³èšºç察å¿ã®ã¯ãªããã¯ãå蚺ããããšã§èªå® ã§è¡ãããšãã§ããã¹ããŒããã©ã³ãéããŠå»åž«ã®èšºå¯ãåããããåŠæ¹ãããGLP-1ãã€ãšããè¬ã¯éµéããŠããããã®ã§ãã¯ãªããã¯ã«éé¢ããæéãããããŸããã
åœèšäºã§ã¯ãGLP-1ãã€ãšãããè¡ãããªã³ã©ã€ã³ã¯ãªããã¯ãå€æ°ã玹ä»ããŸãããããã®äžã§ãéåžžãããå²å®ã«GLP-1è¬ãè³Œå ¥ã§ããååå²åŒãå®æé éå²åŒãªã©ãèšããŠããããããã®ã¯ãªããã¯ãããã¯ã¢ããããã®ã§ãæ°ã«ãªãã¯ãªããã¯ãèŠã€ãã£ããã«ãŠã³ã»ãªã³ã°ã®å蚺ãæ€èšããŠã¿ãŠãã ãããã
ã¯ãªããã¯å | GLP-1ãã€ãšããã®è²»çš | ãããããã€ã³ã |
---|---|---|
DMMãªã³ã©ã€ã³ã¯ãªãã㯠| â å
æè¬ 8,228åïœïŒæ |
å®æé
éå²åŒããïŒ æçåœæ¥ã«è¬ãåãåãã |
ã¯ãªããã¯ãã©ã¢ | â å
æè¬ 9,350åïœïŒæ â æ³šå° 29,700åïŒæ¬ |
24æãŸã§å蚺å¯èœïŒ å®æé éãŸãšãè²·ãã§å²å®ã«ãªã |
TCBæ±äº¬äžå€®çŸå®¹å€ç§ | â æ³šå° åå49,800åïŒæ¬ éåžž75,000åïŒæ¬ |
ååå²åŒäŸ¡æ Œã§æéãæããŠãã€ãšãããå§ãããã |